US 2014/0178395 A1Published application

Treatment of nephropathy

OwnerAlexander Rosendahl, Christopher Mayer +2inventors

InventorsAlexander Rosendahl, Christopher Mayer, Helena Cucak, Lisbeth Nielsen Fink

Life of this patent

Estimating the term…

Abstract

The present invention relates to treatment of nephropathy. In particular, the present invention relates to treatment of nephropathy using therapeutic antibodies.

Claims15

Dependent claims

An IL-21 antibody for use in treating nephropathy, wherein said antibody is an antibody that competes with a receptor for binding to IL-21.

Dependencies are inferred from the claim text.

Facts

Application: 14/135,921Filed 20 Dec 2013
Priority: EP 12198934.721 Dec 2012
Published: 26 Jun 2014
Term ends: Not estimatedThe source records don’t support an estimate.

Classification8 codes

A61K 39/3955
Against materials from animals: against proteinaceous materials, e.g. enzymes, hormones, lymphokines
A61P 13/12
Drugs for disorders of the urinary system: of the kidneys
C07K 16/244
Against cytokines, lymphokines or interferons: interleukins [IL]
A61K 2039/505
Medicinal preparations containing antigens or antibodies: comprising antibodies

Family

Application61/753,129Us provisional application · filed 16 Jan 2013
US 2014/0178395 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results